Doctors worldwide are now conducting The MILO Study, a medical research study for patients with a type of ovarian, fallopian tube, or primary peritoneal cancer called low-grade serous (LGS) cancer. This study will evaluate the effectiveness of an investigational cancer study drug called MEK162, and compare it with other cancer treatments already approved to treat patients with this type of cancer.
If you have LGS ovarian, fallopian tube, or primary peritoneal cancer and your doctor thinks you may be a good candidate for this study, you may want to learn more about this study and consider participating in this study.
The MILO Study is for patients with low-grade serous (LGS) ovarian, fallopian tube, or primary peritoneal cancerMore >
Certain criteria must be met to participate in the clinical trialMore >
A clinical trial is a medical research study designed to investigate new drugs or treatments in humansMore >
Do you have questions? Learn more about the MILO StudyMore >